Article
Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.
PLoS pathogens - 1 Feb 2007
Cheng Cheng, Gall Jason G D, Kong Wing-pui, Sheets Rebecca L, Gomez Phillip L, King C Richter, Nabel Gary J
Abstract excerpt
Recombinant adenoviral (rAd) vectors elicit potent cellular and humoral immune responses and show promise as vaccines for HIV-1, Ebola virus, tuberculosis, malaria, and other infections. These vectors are now widely used and have been generally well tolerated in vaccine and gene therapy clinical trials, with many thousands of people exposed. At the same time, dose-limiting adverse responses have been observed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
